Coronavirus: US to resume use of Johnson & Johnson vaccine

US health officials lifted an 11-day pause on Covid-19 vaccinations using Johnson & Johnson’s single-dose shot on Friday, after scientific advisers decided its benefits outweigh a rare risk of blood clot.The government uncovered 15 vaccine recipients who developed a highly unusual kind of blood clot, out of nearly 8 million people given the J&J shot. All were women, most under age 50. Three died, and seven remain hospitalised.But ultimately on Friday, the Food and Drug Administration and…

Read the original article at South China Morning Post